Skip to content

Continuous Glucose Monitoring System

by Eaglenos Sciences, Inc. EUDAMED

Active European Union

Ref D115L

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number69750225320491CE5LSH Basic UDI-DIDate20 Oct 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED

Device Name
Continuous Glucose Monitoring Device
Model / Reference
D115L
Primary DI / UDI-DI
06975022538708
Basic UDI-DI
69750225320491CE5LSH
Direct Marketing DI
06975022538708
EMDN Code
Z1204011502 Invasive blood sugar monitoring systems
Device Class
Class IIb
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
CN-MF-000036801
Authorised representative
MedPath GmbH DE-AR-000000087

Other devices from Eaglenos Sciences, Inc.

See all devices from Eaglenos Sciences, Inc. →

Properties

  • Sterile
  • Measuring Function

Other properties (11)

  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Incorporates Medicinal Product: No